Presented by: Georg Guebitz, Ph.D., BOKU Vienna, Adva Krivitzky, Ph.D., Tel Aviv University, and Christian Sieg, Ph.D., Wyatt Technology
Presented Live: April 21, 2020
Simple and robust characterization of therapeutic nanoparticles is essential for the development process. Dynamic light scattering (DLS) is ideal for characterizing sub-micron particles when size and size distributions must be measured quickly, with little available material, and when the specific optical properties of the particles are not well known. PALS analysis determines the particle’s zeta potential, which is essential in reducing toxicity and targeting the desired organ.
This webinar consists of three contiguous segments—presented by three speakers—addressing the fundamentals of DLS and how it is used to characterize drug-delivery nanoparticles.